Good news for Thais! The Food and Drug Administration (FDA) of Thailand has announced its readiness to register monkeypox (MPOX) diagnostic test kits, preparing to combat the globally expanding outbreak. This initiative aims to make rapid and accessible diagnostics available nationwide. Deputy Secretary-General Pharmacist Lertchai Lertwut noted that the FDA has established evaluation guidelines for the kits' quality, standards, and safety. It also includes swift facilitation and effective registration, reducing healthcare burdens, and curbing the spread from early stages.
With standardized test kits available domestically, Thailand’s healthcare system will be fortified to better control outbreaks and reduce new infection rates, preparing the nation for potential future monkeypox cases. The FDA has also opened a dedicated service point to expedite kit registration. For more information on the test kits, visit the FDA’s Medical Device Control Division website. (https://medical.fda.moph.go.th/).
This registration reflects Thailand's readiness to tackle pandemics and bolsters public confidence in the country's robust healthcare system!
For More Information: Thai Food and Drug Administration
Link: https://oryor.com/
EN
CN
DE
JP
TH
